NClip

Pag-uulat at Escalation ng Medication Error

4 min na pagbabasa

Pag-uulat at Escalation ng Medication Error

Mahahalagang Punto

  • Ang agarang pag-uulat ng medication errors at adverse reactions ay pangunahing nursing safety duty.
  • Iulat agad ang actual errors at potential errors (near misses) upang suportahan ang prevention learning.
  • Kasama sa escalation ang agarang patient assessment, provider notification, at kumpletong objective documentation.
  • Ang standardized terminology at approved abbreviations ay nagpapababa ng secondary documentation errors.
  • Ang event reporting ay systems-learning safety process, hindi blame process.
  • Maaaring lumitaw kaagad o delayed ang injection-related adverse outcomes, kaya dapat tumugma ang follow-up monitoring windows sa medication risk profile.
  • Ihiwalay ang preventable medication errors sa nonpreventable adverse drug reactions upang tama ang escalation at prevention actions.

Medication-error systems model showing layered defenses and alignment of latent and active failures Illustration reference: OpenStax Pharmacology Ch.3.2.

Kagamitan

  • MAR at full medical record access
  • Facility medication-event reporting tool/process
  • Approved abbreviation reference (kabilang ang do-not-use list)
  • Immediate communication channel para sa provider/team notification

Mga Hakbang sa Pamamaraan

  1. Kilalanin ang posibleng medication error, near miss, o adverse reaction habang/pagkatapos ng administration; kung lumitaw ang concern habang injection, itigil agad ang injection.
  2. Suriin agad ang pasyente para sa stability, symptom severity, at kinakailangang urgent intervention.
  3. Abisuhan agad ang provider at angkop na clinical leadership ayon sa policy.
  4. Isagawa ang anumang agarang safety orders at ipagpatuloy ang close monitoring.
  5. Idokumento ang objective event details sa MAR/progress note, kabilang ang time, medication, dose, route, at observed response.
  6. Para sa infusion errors, idokumento ang pump-programming details (drug library use/bypass, channel assignment, rate units, at total volume infused estimate).
  7. Isama ang provider notification details at additional orders na natanggap.
  8. Kumpletuhin ang kinakailangang incident/variance-report workflow ayon sa organizational policy, kabilang ang near misses at potential errors.
  9. Abisuhan ang unit leadership/risk-management pathways ayon sa policy upang marepaso ang system contributors (orientation, competency validation, handoff process, device safeguards).
  10. Kung natutugunan ang severe-harm criteria, i-activate ang facility sentinel-event escalation o RCA pathways ayon sa policy.
  11. Panatilihing hiwalay ang incident-report content sa medical record; sa chart, idokumento lamang ang clinical event, provider notification, at interventions.
  12. Kung may natukoy na charting error, itama agad gamit ang angkop na record method (electronic edit trail o single-line paper correction na may date/initials).
  13. Gumamit lamang ng approved abbreviations at iwasan ang error-prone shorthand o symbols.
  14. Muling tasahin ang tugon ng pasyente pagkatapos ng interventions at idokumento ang outcome trends.
  15. I-communicate ang relevant findings sa handoff upang mapanatili ang continuity at safety.
  16. Para sa actual administration errors, idokumento at i-trend ang tugon ng pasyente pagkatapos ng interventions upang suportahan ang tuloy-tuloy na risk detection.
  17. Ipagpatuloy ang follow-up monitoring kapag posible ang delayed reactions (halimbawa evolving rash, bleeding, o anaphylaxis signs matapos ang initial stability).
  18. I-classify ang reaction type sa clinical note at handoff: medication error (preventable), adverse drug event (harm mula sa drug exposure), o adverse drug reaction (harm sa kabila ng angkop na paggamit).
  19. Para sa serious o unexpected adverse drug reactions, sundin ang facility pathway para sa FDA MedWatch reporting bukod sa internal safety reporting.

Karaniwang Pagkakamali

  • Naantalang pag-uulat pagkatapos ng adverse response → mas mabagal na paggamot at mas mataas na harm risk.
  • Hindi kumpletong event details → hindi ligtas na handoff at mahinang root-cause follow-up.
  • Independent double-check na hindi kasama ang pump settings/rate units → high-severity infusion error risk.
  • Hindi pag-trigger ng sentinel-event pathway kapag natugunan ang criteria → delayed system response at repeat harm risk.
  • Paggamit ng nonapproved abbreviations → misinterpretation at paulit-ulit na errors.
  • Hindi pag-reassess pagkatapos ng escalation → napapalampas na ongoing deterioration.

Kaugnay

Graph View

Mga Backlink